Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It will be hard enough to put one new member on the board, a slate of new board

I believe that settlement of litigation referenced in SEC filings could constitute a qualifying event, but will leave it to those charged with SEC compliance to determine if Sirius meets the qualification.

If nothing is heard within the deadline, then it didn't.

.

.

.

Be well

Share
New Message
Please login to post a reply